MaxCyte, Inc.
MXCT
$1.39
-$0.03-2.11%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.51M | 10.39M | 8.69M | 8.16M | 10.43M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.51M | 10.39M | 8.69M | 8.16M | 10.43M |
| Cost of Revenue | 1.52M | 1.50M | 2.28M | 1.93M | 1.49M |
| Gross Profit | 6.99M | 8.89M | 6.41M | 6.24M | 8.94M |
| SG&A Expenses | 13.87M | 14.22M | 13.68M | 13.95M | 14.26M |
| Depreciation & Amortization | 1.08M | 1.06M | 1.02M | 1.02M | 1.03M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.73M | 22.69M | 21.59M | 22.22M | 22.40M |
| Operating Income | -14.23M | -12.30M | -12.90M | -14.05M | -11.97M |
| Income Before Tax | -12.36M | -10.26M | -10.60M | -11.56M | -9.38M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.36M | -10.26M | -10.60M | -11.56M | -9.38M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.36M | -10.26M | -10.60M | -11.56M | -9.38M |
| EBIT | -14.23M | -12.30M | -12.90M | -14.05M | -11.97M |
| EBITDA | -13.13M | -11.20M | -11.84M | -12.99M | -10.89M |
| EPS Basic | -0.12 | -0.10 | -0.10 | -0.11 | -0.09 |
| Normalized Basic EPS | -0.07 | -0.06 | -0.06 | -0.07 | -0.06 |
| EPS Diluted | -0.12 | -0.10 | -0.10 | -0.11 | -0.09 |
| Normalized Diluted EPS | -0.07 | -0.06 | -0.06 | -0.07 | -0.06 |
| Average Basic Shares Outstanding | 106.40M | 105.95M | 105.55M | 105.11M | 104.64M |
| Average Diluted Shares Outstanding | 106.40M | 105.95M | 105.55M | 105.11M | 104.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |